Deerfield Management Company, L.P. (Series C) Pulmonx Corp Call Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LUNG
# of Institutions
115Shares Held
33.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA5.16MShares$8.63 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$5.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.83 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$2.01 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $62.2M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...